These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9498462

  • 1. In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination.
    Hacker UT, Jelinek T, Erhardt S, Eigler A, Hartmann G, Nothdurft HD, Endres S.
    J Infect Dis; 1998 Mar; 177(3):774-8. PubMed ID: 9498462
    [Abstract] [Full Text] [Related]

  • 2. Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination.
    Hacker UT, Erhardt S, Tschöp K, Jelinek T, Endres S.
    Clin Exp Immunol; 2001 Sep; 125(3):465-9. PubMed ID: 11531955
    [Abstract] [Full Text] [Related]

  • 3. Circulating and ex vivo production of pyrogenic cytokines and interleukin-1 receptor antagonist in 123 patients with fever of unknown origin. The Netherlands Fever of Unknown Origin Study Group.
    de Kleijn EM, Drenth JP, Pesman GJ, van Druten H, Demacker PN, van der Meer JW.
    J Infect Dis; 1997 Jan; 175(1):191-5. PubMed ID: 8985219
    [Abstract] [Full Text] [Related]

  • 4. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.
    Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW.
    J Appl Physiol (1985); 1995 Nov; 79(5):1497-503. PubMed ID: 8594005
    [Abstract] [Full Text] [Related]

  • 5. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
    Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y.
    Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM, McBride WT, Armstrong MA, McClean E, MacGowan SW, Campalani G, McMurray TJ.
    Cytokine; 2002 Jan 21; 17(2):61-5. PubMed ID: 11886172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.
    Millo JL, Schultz MJ, Williams C, Weverling GJ, Ringrose T, Mackinlay CI, van der Poll T, Garrard CS.
    Intensive Care Med; 2004 Jan 21; 30(1):68-74. PubMed ID: 14634726
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage.
    Mathiesen T, Edner G, Ulfarsson E, Andersson B.
    J Neurosurg; 1997 Aug 21; 87(2):215-20. PubMed ID: 9254084
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, Kamei Y, Shimamura T, Suzuki T, Taniguchi S, Yoshida M.
    J Med; 1996 Aug 21; 27(1-2):57-71. PubMed ID: 8863178
    [Abstract] [Full Text] [Related]

  • 14. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome.
    Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A.
    J Infect Dis; 1996 Jan 21; 173(1):38-43. PubMed ID: 8537680
    [Abstract] [Full Text] [Related]

  • 15. Activation of the cytokine network and unfavorable outcome in patients with yellow fever.
    ter Meulen J, Sakho M, Koulemou K, Magassouba N, Bah A, Preiser W, Daffis S, Klewitz C, Bae HG, Niedrig M, Zeller H, Heinzel-Gutenbrunner M, Koivogui L, Kaufmann A.
    J Infect Dis; 2004 Nov 15; 190(10):1821-7. PubMed ID: 15499539
    [Abstract] [Full Text] [Related]

  • 16. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA, Grosen EA, Ioli GR, Van Eden ME, Brightbill HD, Gatanaga M, DiSaia PJ, Granger GA, Gatanaga T.
    Gynecol Oncol; 1994 Nov 15; 55(2):294-303. PubMed ID: 7959299
    [Abstract] [Full Text] [Related]

  • 17. Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.
    Barrett ADT.
    Vaccine; 2017 Oct 20; 35(44):5951-5955. PubMed ID: 28366605
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA.
    Kidney Int Suppl; 1992 Oct 20; 38():S68-77. PubMed ID: 1328757
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB, Shopp GM.
    Immunopharmacol Immunotoxicol; 1996 Aug 20; 18(3):397-419. PubMed ID: 8872492
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG, Hancu N, Blok WL, Grigorescu-Sido P, Popa L, Popa V, van der Meer JW.
    Cytokine; 1997 Apr 20; 9(4):284-7. PubMed ID: 9112337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.